Metraipolis › archive › dc_e24a79d35e99

Barriers and facilitators to non-pharmacological management of metabolic dysfunction-associated steatotic liver disease: a qualitative evidence synthesis — Europe PMC PMID:40949142

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40949142
DOI
10.3389/fphar.2025.1615809
License (as archived)
solo-consultazione
Archived
2026-11-10T06:22:31.820Z
SHA-256 of the archived text
34ebdac9fdbe86b3ff3e355b03f1f01c0ecd15c42370e15e2541dc866b26197c
Stable URL of this page
https://metraipolis.com/documento/dc_e24a79d35e99

How to cite

Barriers and facilitators to non-pharmacological management of metabolic dysfunction-associated steatotic liver disease: a qualitative evidence synthesis — Europe PMC PMID:40949142 — Europe PMC (en), https://europepmc.org/article/MED/40949142 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e24a79d35e99 (Metraipolis archive dc_e24a79d35e99, sha256 34ebdac9fdbe86b3ff3e355b03f1f01c0ecd15c42370e15e2541dc866b26197c)
BibTeX
@misc{dce24a79d35e99,
  title = {Barriers and facilitators to non-pharmacological management of metabolic dysfunction-associated steatotic liver disease: a qualitative evidence synthesis — Europe PMC PMID:40949142},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40949142},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e24a79d35e99; sha256 34ebdac9fdbe86b3ff3e355b03f1f01c0ecd15c42370e15e2541dc866b26197c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40949142. Agents can read the archived copy with the MCP tool read_document.